Keng-li Lan - Publications

Modulated electro-hyperthermia enhances tumor cell susceptibility to γδ T cell-mediated cytotoxicity and tumor infiltration in NOD/SCID xenograft models.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: June 24, 2026

An IL-15 fusion with albumin-binding domain boosts immunotherapy therapy in glioblastoma via FGF-2 competition regulating FGFR1/2.

Journal: Cancer letters

Published: October 07, 2025

Revisiting fractionation in prostate carbon ion therapy: first comparative analysis of biologically effective dose using mMKM with diverse parameters.

Journal: Radiation oncology (London, England)

Published: September 13, 2025

Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 18, 2025

TPL2 Promotes Gastric Cancer Progression and Chemoresistance Through a Hypoxia-Induced Positive Feedback Loop with PPARδ.

Journal: International journal of biological sciences

Published: February 12, 2025

Feasibility and safety of Taipei Veterans General Hospital Heavy Ion Therapy Center: The first carbon-ion irradiation facility in Taiwan.

Journal: Journal of the Chinese Medical Association : JCMA

Published: January 16, 2025

The potential of integrating stereotactic ablative radiotherapy techniques with hyperfractionation for lung cancer.

Journal: Thoracic cancer

Published: April 12, 2024

Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma.

Journal: Journal of the Chinese Medical Association : JCMA

Published: March 13, 2024

A multifunctional PEGylated liposomal-encapsulated sunitinib enhancing autophagy, immunomodulation, and safety in renal cell carcinoma.

Journal: Journal of nanobiotechnology

Published: January 26, 2024

Characterization of tumoricidal activities mediated by a novel immune cell regimen composing interferon-producing killer dendritic cells and tumor-specific cytotoxic T lymphocytes.

Journal: BMC cancer

Published: December 12, 2023

Old age and EGFR mutation status in inoperable early-stage non-small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan.

Journal: Thoracic cancer

Published: November 19, 2022

Aryl hydrocarbon receptor deficiency augments dysregulated microangiogenesis and diabetic retinopathy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 29, 2022